Here, we show that Notch-3-dependent ERK activation in breast cancer via IL-6 targets the activation of Jagged-1, which belongs to a family of Notch ligands and CA-IX, a hypoxia survival gene. The gene discussed is IL6; the disease is breast carcinoma.